Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1831 (LINC01831) is a long intergenic non-coding RNA (lincRNA) found in the human genome. It is defined as a non-coding transcript longer than 200 nucleotides that does not overlap protein-coding genes. LINC01831 is annotated in authoritative databases such as GeneCards and NCBI Gene (accession number 101927331) and Ensembl (ENSG00000225765) as a non-protein-coding transcript with unknown function. There are no peer-reviewed studies directly characterizing the function, disease association, or therapeutic relevance of LINC01831 as of current data. While lincRNAs as a family may act in the regulation of gene expression, modification of chromatin state, genome architecture, and other cellular processes, specific evidence for these functions in LINC01831 is lacking. No drugs, disease associations, or biomarkers have been described for LINC01831 in curated gene or biomedical databases. There is no evidence in public databases or literature to classify LINC01831 as a therapeutic target (receptor, enzyme, transporter, etc.).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1831 (LINC01831).